Volume of Distribution in Drug Design

Journal of Medicinal Chemistry

Volumn 58, Issue 15, 2015, Pages 5691-5698

  Smith, Dennis A ^a   Beaumont, Kevin ^b   Maurer, Tristan S ^b   Di, Li ^b  

^a 4 the Maltings ^*  (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL MOLECULE TRANSPORT AGENT;

ACTIVE TRANSPORT; ARTICLE; DRUG CONCENTRATION; DRUG DESIGN; DRUG DISPOSITION; DRUG HALF LIFE; ENTEROHEPATIC CIRCULATION; IONIZATION; LIPOPHILICITY; MODULATION; NONHUMAN; PH; PHARMACOKINETICS; PHYSICAL CHEMISTRY; VOLUME OF DISTRIBUTION; HALF LIFE TIME;

DRUG DESIGN; HALF-LIFE; PHARMACOKINETICS;

EID: 84938919255     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/acs.jmedchem.5b00201     Document Type: Article

References (32)

1. Wagner, J. G. Significance of ratios of different volumes of distribution in pharmacokinetics Biopharm. Drug Dispos. 1983, 4, 263-270
2. Gillette, J. R. Factors affecting drug metabolism Ann. N.Y. Acad. Sci. 1971, 179, 43-66
3. Øie, S.; Tozer, T. N. Effect of altered plasma protein binding on apparent volume of distribution J. Pharm. Sci. 1979, 68, 1203-1205
4. Rowland, M.; Tozer, T. N. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications, 4 th ed.; Lippincott Williams & Wilkins: Philadelphia, PA, 2010.
5. Berry, L. M.; Roberts, J.; Be, X.; Zhao, Z.; Lin, M.-H. J. Prediction of Vss from in vitro tissue-binding studies Drug Metab. Dispos. 2010, 38, 115-121
6. Rodgers, T.; Rowland, M. Mechanistic approaches to volume of distribution predictions: understanding the processes Pharm. Res. 2007, 24, 918-933
7. Murakami, T.; Yumoto, R. Role of phosphatidylserine binding in tissue distribution of amine-containing basic compounds Expert Opin. Drug Metab. Toxicol. 2011, 7, 353-364
8. Yata, N.; Toyoda, T.; Murakami, T.; Nishiura, A.; Higashi, Y. Phosphatidylserine as a determinant for the tissue distribution of weakly basic drugs in rats Pharm. Res. 1990, 7, 1019-1025
9. Ghosh, A.; Scott, D. O.; Maurer, T. S. Towards a unified model of passive drug permeation I: Origins of the unstirred water layer with applications to ionic permeation Eur. J. Pharm. Sci. 2014, 52, 109-124
10. Maurer, T. S.; DeBartolo, D. B.; Tess, D. A.; Scott, D. O. Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice Drug Metab. Dispos. 2005, 33, 175-181
11. Faulkner, J. K.; McGibney, D.; Chasseaud, L. F.; Perry, J. L.; Taylor, I. W. The pharmacokinetics of amlodipine in healthy volunteers after single intravenous and oral doses and after 14 repeated oral doses given once daily Br. J. Clin. Pharmacol. 1986, 22, 21-25
12. Abernethy, D. R.; Schwartz, J. B. Pharmacokinetics of calcium antagonists under development Clin. Pharmacokinet. 1988, 15, 1-14
13. Hamann, S. R.; Piascik, M. T.; McAllister, R. G., Jr. Aspects of the clinical pharmacology of nifedipine, a dihydropyridine calcium-entry antagonist Biopharm. Drug Dispos. 1986, 7, 1-10
14. Welling, P. G.; Craig, W. A. Pharmacokinetics of intravenous erythromycin J. Pharm. Sci. 1978, 67, 1057-1059
15. Luke, D. R.; Foulds, G.; Cohen, S. F.; Levy, B. Safety, toleration, and pharmacokinetics of intravenous azithromycin Antimicrob. Agents Chemother. 1996, 40, 2577-2581
16. Foulds, G.; Shepard, R. M.; Johnson, R. B. The pharmacokinetics of azithromycin in human serum and tissues J. Antimicrob. Chemother. 1990, 25, 73-82
17. Hay, T.; Jones, R.; Beaumont, K.; Kemp, M. Modulation of the partition coefficient between octanol and buffer at pH 7.4 and pKa to achieve the optimum balance of blood clearance and volume of distribution for a series of tetrahydropyran histamine type 3 receptor antagonists Drug Metab. Dispos. 2009, 37, 1864-1870
18. Manoury, P. M.; Binet, J. L.; Rousseau, J.; Lefevre-Borg, F. M.; Cavero, I. G. Synthesis of a series of compounds related to betaxolol, a new β1-adrenoceptor antagonist with a pharmacological and pharmacokinetic profile optimized for the treatment of chronic cardiovascular diseases J. Med. Chem. 1987, 30, 1003-1011
19. Manners, C. N.; Payling, D. W.; Smith, D. A. Distribution coefficient, a convenient term for the relation of predictable physicochemical properties to metabolic processes Xenobiotica 1988, 18, 331-350
20. Higgins, J. W.; Bao, J. Q.; Ke, A. B.; Manro, J. R.; Fallon, J. K.; Smith, P. C.; Zamek-Gliszczynski, M. J. Utility of Oatp1a/1b-knockout and OATP1B1/3-humanized mice in the study of OATP-mediated pharmacokinetics and tissue distribution: case studies with pravastatin, atorvastatin, simvastatin, and carboxydichlorofluorescein Drug Metab. Dispos. 2014, 42, 182-192
21. van de Steeg, E.; Wagenaar, E.; van der Kruijssen, C. M. M.; Burggraaff, J. E. C.; de Waart, D. R.; Oude Elferink, R. P. J.; Kenworthy, K. E.; Schinkel, A. H. Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs J. Clin. Invest. 2010, 120, 2942-2952
22. Grover, A.; Benet, L. Z. Effects of drug transporters on volume of distribution AAPS J. 2009, 11, 250-261
23. Roberts, M. S.; Magnusson, B. M.; Burczynski, F. J.; Weiss, M. Enterohepatic circulation: physiological, pharmacokinetic and clinical implications Clin. Pharmacokinet. 2002, 41, 751-790
24. Davies, N. M.; Takemoto, J. K.; Brocks, D. R.; Yanez, J. A. Multiple peaking phenomena in pharmacokinetic disposition Clin. Pharmacokinet. 2010, 49, 351-377
25. Deng, J.; Zhuang, X.; Shen, G.; Li, H.; Gong, Z. Biliary excretion and enterohepatic circulation of thienorphine and its glucuronide conjugate in rats Acta Pharm. Sin. B 2012, 2, 174-180
26. Benveniste, C.; Striberni, R.; Dayer, P. Indirect assessment of the enterohepatic recirculation of piroxicam and tenoxicam Eur. J. Clin. Pharmacol. 1990, 38, 547-549
27. Gibiansky, L.; Gibiansky, E. Target-mediated drug disposition model: approximations, identifiability of model parameters and applications to the population pharmacokinetic-pharmacodynamic modeling of biologics Expert Opin. Drug Metab. Toxicol. 2009, 5, 803-812
28. Yamazaki, S.; Shen, Z.; Jiang, Y.; Smith, B. J.; Vicini, P. Application of target-mediated drug disposition model to small molecule heat shock protein 90 inhibitors Drug Metab. Dispos. 2013, 41, 1285-1294
29. Obach, R. S.; Lombardo, F.; Waters, N. J. Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds Drug Metab. Dispos. 2008, 36, 1385-1405
30. Hardman, J. G.; Limbird, L. E.; Gilman, A. G. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 10 th ed.; McGraw-Hill Professional: New York, 2001.
31. Atkinson, A. J., Jr.; Bennett, J. E. Amphotericin B pharmacokinetics in humans Antimicrob. Agents Chemother. 1978, 13, 271-276
32. Kwon, Y. Handbook of Essential Pharmacokinetics, Pharmacodynamics, and Drug Metabolism for Industrial Scientists; Kluwer Academic/Plenum Publishers: New York, 2001.